Kingdom Investment Holdings is the parent hub for innovation, impact, and integration. Through strategic ownership and oversight, KIH unites a family of ventures that span intellectual property licensing, advanced compounding systems, travel services, and charitable initiatives.

• SubMagna^® HMW – an industry-leading sublingual compounding base for high molecular weight medications such as GLP-1s, Sermorelin and NAD (among others)
• BASSAGEL™ – a water-washable, hydrating ointment trusted for multiple conditions
• Kingdom Licensing – holder of 60+ issued U.S. patents, licensing entities nationwide
• KIH-GPO – a group purchasing organization focused on helping pharmacies lower costs
• Kingdom Luxe Travel – a travel agency donating 50% of its revenue to charities

At its core, Kingdom Investment Holdings is more than products and patents – it is about linking innovation and commerce to global philanthropy, ensuring that every adoption of our approaches helps fund charitable causes worldwide.